The significant impact of CD24 knockdown in male mice on the rate of BBN-induced bladder cancer development was not seen in female mice (wild-type: 33% vs. CD24-deficient: 24% at 16 weeks) [71], implying the involvement of AR signaling in CD24-mediated urothelial tumorigenesis. The gene discussed is AR; the disease is urinary bladder cancer.